This guideline together with the Guideline on Quality of Transdermal Patches replaces Note for Guidance on Modified Release products: A: Oral dosage Forms B: Transdermal Dosage Forms. Part I (Quality).
Go to Source

This entry was posted on Friday, September 14th, 2012 at 11:30 am and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.